packageIbalizumab

ibalizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ibalizumab is a monoclonal antibody used as an antiviral treatment for HIV infections. It is an approved drug, though its marketing authorisation in the European Union has been withdrawn, so its use is now mainly elsewhere.

Summary written by glm-5.3-flash from Wikidata Q3791531 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ibalizumab
ATC codes:J05AX23
DrugBank:DB12698
Wikidata:Q3791531

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown